ABOS Competitors & Alternatives
Compare Acumen Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ABOS
Main Stock$2.41
Tradestie Score
57
Market Cap
$106.00M
Analyst Upside
+207.1%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$30.86
|
$256.54M | - | 61 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$9.07
|
$211.22M | - | 56 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.92
|
$202.58M | - | 59 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$26.80
|
$188.81M | 326.3 | 53 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$17.83
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.01
|
$158.43M | - | 53 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.30
|
$133.50M | - | 66 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.39
|
$114.01M | - | 58 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.44
|
$110.20M | - | 61 | Compare |
More ABOS Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry